Navigation Links
Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
Date:9/24/2007

ogy to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit http://www.modigeneinc.com.

Safe Harbor Statement: This press release contains forward-looking statements, including statements regarding the results of current studies and preclinical experiments and the effectiveness of Modigene's long-acting protein programs and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risks and uncertainties that may affect Modigene's business and prospects, including the risks that Modigene may not succeed in developing any commercial products based upon its long- acting protein technology, including any long-acting versions of human growth hormone, erythropoietin, interferon beta or GLP-1; that the long-acting products in development may fail, may not achieve the expected results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical ind
'/>"/>

SOURCE Modigene Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Calif., Sept. 18, 2014  PRO-DEX, INC. (NasdaqCM: PDEX) ... quarter and full-year ended June 30, 2014. ... three months ended June 30, 2014 increased $492,000, or ... three months ended June 30, 2013, due primarily to ... repair revenues from the Company,s largest customer, partially offset ...
(Date:9/18/2014)... Research and Markets has announced ... Investment Report, 2014-2016" report to their offering. ... in percutaneous coronary intervention (PCI), serves not only as ... device for pre-/post-stent dilatations. Therefore, the development of PTCA ... As national economy develops and people,s living ...
(Date:9/18/2014)... 2014  Iliad Neurosciences, Inc., a company focused on ... Autism Spectrum Disorders (ASD) announced today that it has ... Foundation for The State University of New York. ... biomarker to identify an abnormality in folate transport to ... is expected to be available for research use by ...
Breaking Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3
... Inc. (Nasdaq: NBIX ) announced today that the Company ... Nasdaq market closes on Wednesday, October 28, 2009. ... webcast to discuss its financial results and provide a Company ... Daylight Time (5:30 a.m. Pacific Daylight Time). , Participants can ...
... 21 National Disability Employment Awareness Month marks the ... New Mobility magazine, the cutting-edge voice of disability ... www.newmobility.com ), written and edited by staff and ... users into mainstream society, while simultaneously reflecting the vibrant ...
Cached Medicine Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results 2Award-Winning Disability Lifestyle Magazine Celebrates 20 Years of Publication - And 20 Years of Employing People with Disabilities 2
(Date:9/19/2014)... in infertile land, and bear many beans that are ... most legumes have a symbiotic relationship with bacteria, called ... then supply the host plant with ammonia as a ... nodules in their roots. However, if too many root ... of the plants, because the energy cost of maintaining ...
(Date:9/19/2014)... Lifeinsuranceprices.info has released a new blog post announcing ... online. , Clients who smoke or use other ... quotes from multiple providers on a single website. Insurance ... Smoking will always influence life insurance prices, in a ... for life coverage and if they have health issues, ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 InventHelp, ... its clients, an inventor from New York, has created an ... patient from inclement weather or smoke during transport. This ... snapped to a stretcher and remain in place until removed, ... for a more comfortable move with protection from irritating smoke ...
(Date:9/19/2014)... 19, 2014 Outsourcing services provider Profit By ... US IT conglomerate to provide HR outsourcing services in India. ... an exclusive partner and will act as a talent acquisition ... deploy over 120 personnel across 3 locations in India in ... , "This is a significant win for us and we ...
(Date:9/19/2014)... FL (PRWEB) September 19, 2014 Dr. ... introduced Therapeutic Periodontal Treatment to their Miami practice. ... Dr. Gallardo and Dr. Lamas are one of ... the ‘total health’ approach for diagnosing and treating periodontal ... of the most under-diagnosed and under-treated diseases in the ...
Breaking Medicine News(10 mins):Health News:Long-distance communication from leaves to roots 2Health News:Smokers Can Compare Term Life Insurance Quotes At Lifeinsuranceprices.info! 2Health News:InventHelp® Client Patents “Patient Protector” – Designed to Protect Patients During Transport 2Health News:Profit By RPO Bags huge RPO contract from US-based Implementation Partner 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3
... study conducted by the researchers at New York University School ... Asian immigrants are carriers// of the hepatitis B virus. These ... But it is surprising to know that most of the ... people who are infected had no health insurance. The rate ...
... place on record the exemplary work of art by students from ... by Oman in the ‘Unite for children Unite against Aids’ campaign ... for Children Unite Against Aids’ campaign encompasses four major goals spread ... percentage of the young victims of HIV/Aids; to provide better services ...
... Health workers by the Ontario government, to beat a possible ... from critics // , who see this is politically motivated ... The opinion doing the rounds is that the kits ... ,According to health minister George Smitherman, 15,000 emergency kits will ...
... Exercising for at least for half an hour a day and ... serving of vegetables and fish, may be the key// to longevity ... Health Organization. ,According to the study, exercising just 30 ... cycling and even climbing the stairs are included in the tally, ...
... University have developed ,the first knee replacement shaped to ... the U.S. Food and Drug Administration, and will be ... ,Dr. Aaron G. Rosenberg and Dr. Richard A. Berger, ... who sought to address shape-related differences of a woman’s ...
... A systematic review of studies has revealed that surgery ... intrauterine medication for women experiencing heavy periods in reducing ... ,However, on subjective measures of effectiveness — satisfaction and ... (IUD) is as effective as surgery, the review found. ...
Cached Medicine News:Health News:East Asian Immigrants Bring Hepatitis to New York 2Health News:Shapelier Knee Replacements for Women 2Health News:Shapelier Knee Replacements for Women 3Health News:Shapelier Knee Replacements for Women 4Health News:Surgery or IUD for Heavy Periods 2Health News:Surgery or IUD for Heavy Periods 3
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard knife with box, C profile...
... is a refrigerated design for use as a ... with the 8000 sledge microtome, however, it can ... stage gives a large working area of 130 ... provide good adhesion between the specimen and the ...
Medicine Products: